权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

2012 Metals in Medicine Gordon Research Conference

2012 年戈登医学金属研究会议

基本信息

批准号：
8392621
负责人：
Dean Sherry
金额：
$ 1.5万
依托单位：
GORDON RESEARCH CONFERENCES
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-06-20 至 2013-05-19
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8392621
关键词：
Academia Address Area Attention Award Biochemical Process Biological Process Carbon Chemistry Cisplatin Clinic Clinical Collaborations Communities Contrast Media Development Disease Doctor of Philosophy Educational process of instructing Environment Feedback Funding Future Generations Government Health Image Individual Industry Inorganic Chemistry Interdisciplinary Study Ions Laboratories Learning Magnetic Resonance Imaging Medical Medicine Metals Oral Pharmaceutical Chemistry Pharmaceutical Preparations Pharmacologic Substance Pharmacotherapy Postdoctoral Fellow Radiopharmaceuticals Research Research Personnel Science Scientist Students Translations Travel United States National Institutes of Health Work base career design drug development human disease interest meetings novel novel therapeutics organic base posters success symposium

项目摘要

DESCRIPTION (provided by applicant): Inorganic medicinal chemistry continues as an emerging field with tremendous potential for development of new metal-based drugs for therapy, imaging and other medical applications. The 2012 Metals-in-Medicine GRC will bring together PhD scientists and clinicians from academia, industry and government to discuss the latest developments in the field known as medicinal inorganic chemistry in the relaxed environment of a Gordon Research Conference. We will attract as many students, postdocs and young investigators to this meeting as possible by offering conference stipends and small travel awards to a few individuals and by bringing attention to a few young investigators who bring their best ideas to the meeting through oral poster presentations. The organizers of the 2012 Metals-in-Medicine Gordon Research Conference (GRC) have four specific aims. First, is to illustrate and teach about the successes of recently approved metal-based drugs. Second, our invited speakers will illustrate new research opportunities in important health-related disorders. Third, encourage future generations of young scientists to get involved with interdisciplinary research early in their careers. Several young investigators who attend will be offered an opportunity to present their work orally at our afternoon poster sessions. The more senior leading investigators in the field will be asked to participate in these presentation by offering them guidance and feedback. Fourth, to provide a nucleating forum for researchers in medicinal inorganic chemistry. We believe that bringing together the most prominent researchers in academics, pharmaceutical development, government labs and clinicians from around the world will provide a fertile ground for exchange of ideas and opportunities for new collaborations. PUBLIC HEALTH RELEVANCE: The importance of metal ions in controlling many biochemical processes is often overlooked in the design of new therapeutics in favor of organic-based drugs. Nevertheless, the importance of Fe, Ca, Mg, Cu and Zn chemistry in controlling biological processes cannot be overstated in the design of new drugs for many human diseases. The 2012 Metals-in-Medicine GRC will bring together PhD scientists and clinicians from academia, industry and government to discuss the latest developments in the field known as medicinal inorganic chemistry in the relaxed environment of a Gordon Research Conference.

描述（由申请人提供）：无机药物化学仍然是一个新兴领域，具有开发用于治疗、成像和其他医学应用的新型金属基药物的巨大潜力。2012年医学中的金属GRC将汇集来自学术界，工业界和政府的博士科学家和临床医生，在戈登研究会议的轻松环境中讨论药用无机化学领域的最新发展。我们将通过向少数人提供会议津贴和小额旅行奖励，并通过口头海报演示来吸引尽可能多的学生、博士后和年轻研究人员参加这次会议。2012年医学金属戈登研究会议（GRC）的组织者有四个具体目标。首先，是说明和教导最近批准的金属基药物的成功。其次，我们邀请的演讲者将说明重要的健康相关疾病的新研究机会。第三，鼓励未来几代年轻科学家在职业生涯早期参与跨学科研究。几位年轻的研究者将有机会在下午的海报会议上口头介绍他们的工作。将邀请该领域较资深的主要研究人员参加这些介绍，向他们提供指导和反馈。第四，为药物无机化学研究人员提供一个成核论坛。我们相信，汇集来自世界各地的学术界、药物开发、政府实验室和临床医生中最杰出的研究人员，将为交流思想和新的合作机会提供肥沃的土壤。公共卫生关系：金属离子在控制许多生物化学过程中的重要性在设计有利于有机药物的新疗法时经常被忽视。然而，在设计用于许多人类疾病的新药时，Fe、Ca、Mg、Cu和Zn化学在控制生物过程中的重要性不能被夸大。2012年医学中的金属GRC将汇集来自学术界，工业界和政府的博士科学家和临床医生，在戈登研究会议的轻松环境中讨论药用无机化学领域的最新发展。